| Literature DB >> 30406960 |
Reuven Edri1,2, Idan Gal1, Nadav Noor3, Tom Harel1, Sharon Fleischer1, Nofar Adadi3, Ori Green4, Doron Shabat4, Lior Heller5, Assaf Shapira1, Irit Gat-Viks1, Dan Peer1,2,3, Tal Dvir1,2,3,6,7.
Abstract
Despite incremental improvements in the field of tissue engineering, no technology is currently available for producing completely autologous implants where both the cells and the scaffolding material are generated from the patient, and thus do not provoke an immune response that may lead to implant rejection. Here, a new approach is introduced to efficiently engineer any tissue type, which its differentiation cues are known, from one small tissue biopsy. Pieces of omental tissues are extracted from patients and, while the cells are reprogrammed to become induced pluripotent stem cells, the extracellular matrix is processed into an immunologically matching, thermoresponsive hydrogel. Efficient cell differentiation within a large 3D hydrogel is reported, and, as a proof of concept, the generation of functional cardiac, cortical, spinal cord, and adipogenic tissue implants is demonstrated. This versatile bioengineering approach may assist to regenerate any tissue and organ with a minimal risk for immune rejection.Entities:
Keywords: autologous; decellularized hydrogels; induced pluripotent stem cells; non-immunogenic; tissue engineering
Mesh:
Substances:
Year: 2018 PMID: 30406960 DOI: 10.1002/adma.201803895
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849